Jump to content

Patented Medicine Prices Review Board

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rathfelder (talk | contribs) at 21:30, 16 September 2018 (removed Category:Medical and health organizations based in Canada; added Category:Pharmacy organizations in Canada using HotCat). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

The Patented Medicine Prices Review Board is a government agency in Canada which regulates drugs that are still under patent and which yet have no generic substitutes.

This Board establishes the maximum prices that can be charged in Canada for patented drugs.[1]

References